Skip to main content
Caplight Logo









SCG Cell Therapy

SCG Cell Therapy

Private
SingaporeHealthcare & Life Scienceshttps://www.scgcell.com/

Last Round

Series C

Extension

Apr 5, 2023

Est. Valuation

$210M

Total Funding Raised

$26.3M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

SCG Cell Therapy is a biotechnology company that develops novel immunotherapies for patients with infections and associated cancers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

cell therapyT-cell receptorTCR-Timmunotherapychimeric antigen receptorCAR-Toncologyprecision medicinedrug discoveryclinical trialsviral-associated cancerGMP manufacturingbiotechcell manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SCG Cell Therapy Comparables

Compare SCG Cell Therapy with similar companies based on industry and business-model similarity.

SCG Cell Therapy comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Lion TCR
88%
Beijing CorreGene Biotechnology Co., Ltd.
84%
TCRCure Biopharma
83%

SCG Cell Therapy Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series C ExtensionApr 5, 2023
Series CJun 22, 2021

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Monthly visitors increased 212% MoM.

  • Oct 18, 2025

    Will present at the ESMO 2025 conference.

SCG Cell Therapy Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

SCG Cell Therapy Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SCG Cell Therapy's valuation, stock price, and market status.

Firmographic Details

HeadquartersSingapore
Employee Range23
Year Founded2017
Last FundingApr 5, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?